Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

AMES NATIONAL CORP (ATLO) Stock Forecast 2025 - AI Price Prediction & Analysis

AMES NATIONAL CORP (ATLO) AI Stock Price Forecast & Investment Analysis

AMES NATIONAL CORP Stock Price Chart and Technical Analysis

Loading AMES NATIONAL CORP interactive price chart and technical analysis...

AMES NATIONAL CORP (ATLO) - Comprehensive Stock Analysis & Investment Research

Deep dive into AMES NATIONAL CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about AMES NATIONAL CORP, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For AMES NATIONAL CORP: AMES NATIONAL CORP operates in the Finance sector, making it an emerging small-cap investment.

AMES NATIONAL CORP (Stock Symbol: ATLO) is a leading company in the Finance sector , specifically operating within the National Commercial Banks industry.

The organization employs approximately 10 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing AMES NATIONAL CORP's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For AMES NATIONAL CORP: With $58M in annual revenue and 34.9% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $58 million generating a 34.9% net profit margin .

Market Capitalization: $176 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 12.1% - Above-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for AMES NATIONAL CORP stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For AMES NATIONAL CORP: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for AMES NATIONAL CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: AMES NATIONAL CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For AMES NATIONAL CORP: Strong free cash flow generation demonstrates developing operational efficiency.

AMES NATIONAL CORP strategically competes in the highly dynamic National Commercial Banks marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $26 million annually, complemented by impressive 47.2% year-over-year cash flow growth.

AMES NATIONAL CORP (ATLO) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for AMES NATIONAL CORP stock analysis.

Loading AMES NATIONAL CORP comprehensive fundamental analysis and insider trading data...

Deep dive into AMES NATIONAL CORP's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if AMES NATIONAL CORP stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For AMES NATIONAL CORP: With a P/E ratio of 12.83, the market sees the stock as potentially undervalued.

P/E Ratio 12.83x
P/B Ratio 0.91x
Market Cap $176M
Dividend Yield 3.04%
EPS $1.53
Book Value/Share $21.66
Revenue/Share $6.57
FCF/Share $2.85
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently AMES NATIONAL CORP converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For AMES NATIONAL CORP: An ROE of 12.1% shows good shareholder value creation.

ROE 12.1%
ROA 1.1%
Net Margin 34.9%
EBT Margin 44.7%
Tax Rate 22.0%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess AMES NATIONAL CORP's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For AMES NATIONAL CORP:

D/E Ratio 0.01x
Financial Leverage 12.37x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal AMES NATIONAL CORP's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For AMES NATIONAL CORP: Free cash flow of $26M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $28M
Free Cash Flow $26M
Capital Spending $-2M
OCF Growth YoY 47.2%
FCF Growth YoY 46.7%
FCF/Sales 39.1%
CapEx/Sales 3.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively AMES NATIONAL CORP uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For AMES NATIONAL CORP: An asset turnover of 0.03x suggests room for improvement in asset utilization.

Asset Turnover 0.03x
Fixed Assets Turnover 3.8x
Understanding Financial Statement Data

What these metrics mean: Key figures from AMES NATIONAL CORP's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For AMES NATIONAL CORP: With annual revenue of $58M, AMES NATIONAL CORP represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $58M
SG&A Expense $46M
Balance Sheet Highlights (% Of Assets)
Cash & Short-term Investments 45%
Total Liabilities 92%
Short-term Debt 0%
Accounts Receivable 0%
Dividend & Shareholder Information
Dividends Per Share $0.60
Payout Ratio 0.4%
Shares Outstanding 9M
Growth Metrics (YoY)
EPS Growth 9.8%

Latest AMES NATIONAL CORP Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting AMES NATIONAL CORP (ATLO) stock price and investment outlook.

, source: ETF Daily News

Ames National Co. (NASDAQ:ATLO – Get Free Report) was the target of a significant increase in short interest in December. As of December 15th, there was short interest totalling 49,700 shares, an ...

, source: WTOP News

AMES, Iowa (AP) — AMES, Iowa (AP) — Ames National Corp. (ATLO) on Thursday reported first-quarter net income of $3.4 million. The Ames, Iowa-based bank said it had earnings of 39 cents per share. The ...

, source: News-Press NOW

AMES, Iowa (AP) — AMES, Iowa (AP) — Ames National Corp. (ATLO) on Friday reported second-quarter profit of $4.5 million. The bank, based in Ames, Iowa, said it had earnings of 51 cents per share. The ...

, source: Mankato Free Press

AMES, Iowa (AP) — AMES, Iowa (AP) — Ames National Corp. (ATLO) on Friday reported fourth-quarter profit of $3.5 million. The bank, based in Ames, Iowa, said it had earnings of 39 cents per share. The ...

AMES NATIONAL CORP Competitors & Peer Analysis - Finance Sector

Comparative analysis of AMES NATIONAL CORP against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ALRS Unlock Forecast - 30 Days FREE Trial $534M 13.8x 1.0x
AMJB Unlock Forecast - 30 Days FREE Trial $82107M 1.5x 0.2x
AMTB Unlock Forecast - 30 Days FREE Trial $769M 209.2x 0.8x
AROW Unlock Forecast - 30 Days FREE Trial $434M 14.2x 1.1x
ASRV Unlock Forecast - 30 Days FREE Trial $48M 13.1x 0.4x
ATLO Unlock Forecast - 30 Days FREE Trial $176M 12.8x 0.9x
BAC Unlock Forecast - 30 Days FREE Trial $383941M 13.7x 1.3x
BAC-PB Unlock Forecast - 30 Days FREE Trial $195864M 7.0x 0.7x
BAC-PE Unlock Forecast - 30 Days FREE Trial $166562M 5.9x 0.6x
BAC-PK Unlock Forecast - 30 Days FREE Trial $192163M 6.8x 0.6x
BAC-PL Unlock Forecast - 30 Days FREE Trial $9616252M 342.6x 32.1x
BAC-PM Unlock Forecast - 30 Days FREE Trial $177897M 6.3x 0.6x
BAC-PN Unlock Forecast - 30 Days FREE Trial $163786M 5.8x 0.6x
BAC-PO Unlock Forecast - 30 Days FREE Trial $144971M 5.2x 0.5x
BAC-PP Unlock Forecast - 30 Days FREE Trial $135100M 4.8x 0.5x
BAC-PQ Unlock Forecast - 30 Days FREE Trial $139727M 5.0x 0.5x
BAC-PS Unlock Forecast - 30 Days FREE Trial $156152M 5.6x 0.5x
BACRP Unlock Forecast - 30 Days FREE Trial $1657908M 59.1x 5.5x
BANC Unlock Forecast - 30 Days FREE Trial $2770M 18.8x 0.8x
BANC-PF Unlock Forecast - 30 Days FREE Trial $4115M 27.9x 1.2x
BANF Unlock Forecast - 30 Days FREE Trial $4196M 18.0x 2.4x
BANFP Unlock Forecast - 30 Days FREE Trial $875M 3.7x 0.5x
BFC Unlock Forecast - 30 Days FREE Trial $1284M 18.6x 2.1x
BHRB Unlock Forecast - 30 Days FREE Trial $880M 8.4x 1.1x
BML-PG Unlock Forecast - 30 Days FREE Trial $159159M 5.7x 0.5x
BML-PH Unlock Forecast - 30 Days FREE Trial $158234M 5.6x 0.5x
BML-PJ Unlock Forecast - 30 Days FREE Trial $162668M 5.8x 0.5x
BML-PL Unlock Forecast - 30 Days FREE Trial $157617M 5.6x 0.5x
BOKF Unlock Forecast - 30 Days FREE Trial $8854M 16.5x 1.5x
C Unlock Forecast - 30 Days FREE Trial $183641M 13.0x 0.9x
CAC Unlock Forecast - 30 Days FREE Trial $618M 12.6x 1.0x
CARE Unlock Forecast - 30 Days FREE Trial $427M 13.6x 1.1x
CBNA Unlock Forecast - 30 Days FREE Trial $207M x 1.3x
CBNK Unlock Forecast - 30 Days FREE Trial $485M 11.2x 1.3x
CBU Unlock Forecast - 30 Days FREE Trial $3015M 15.5x 1.6x
CFBK Unlock Forecast - 30 Days FREE Trial $147M 8.2x 0.8x
CFR Unlock Forecast - 30 Days FREE Trial $8227M 13.5x 2.0x
CFR-PB Unlock Forecast - 30 Days FREE Trial $1176M 1.9x 0.3x
CHCO Unlock Forecast - 30 Days FREE Trial $1746M 14.3x 2.3x
CMA Unlock Forecast - 30 Days FREE Trial $10588M 14.6x 1.3x
COF Unlock Forecast - 30 Days FREE Trial $134772M 16.5x 1.2x
COF-PI Unlock Forecast - 30 Days FREE Trial $13040M x 0.1x
COF-PJ Unlock Forecast - 30 Days FREE Trial $12464M x 0.1x
COF-PK Unlock Forecast - 30 Days FREE Trial $12112M x 0.1x
COF-PL Unlock Forecast - 30 Days FREE Trial $11294M x 0.1x
COF-PN Unlock Forecast - 30 Days FREE Trial $11332M x 0.1x
C-PN Unlock Forecast - 30 Days FREE Trial $58891M 4.2x 0.3x
DCOM Unlock Forecast - 30 Days FREE Trial $1285M 29.2x 0.9x
DCOMG Unlock Forecast - 30 Days FREE Trial $1174M 26.6x 0.8x
DCOMP Unlock Forecast - 30 Days FREE Trial $850M 19.3x 0.6x
ENBP Unlock Forecast - 30 Days FREE Trial $114M 6.6x 0.8x
FCF Unlock Forecast - 30 Days FREE Trial $1738M 13.0x 1.2x
FDBC Unlock Forecast - 30 Days FREE Trial $239M 10.1x 1.1x
FFBC Unlock Forecast - 30 Days FREE Trial $2397M 10.0x 0.9x
FHN Unlock Forecast - 30 Days FREE Trial $12553M 14.9x 1.4x
FHN-PC Unlock Forecast - 30 Days FREE Trial $13577M 16.1x 1.5x
FHN-PE Unlock Forecast - 30 Days FREE Trial $13394M 15.9x 1.5x
FHN-PF Unlock Forecast - 30 Days FREE Trial $9872M 11.7x 1.1x
FIISO Unlock Forecast - 30 Days FREE Trial $2638M x 4.4x
FISI Unlock Forecast - 30 Days FREE Trial $533M 8.1x 0.9x
FMCB Unlock Forecast - 30 Days FREE Trial $740M 8.2x 1.2x
FNB Unlock Forecast - 30 Days FREE Trial $5784M 12.4x 0.9x
FNLC Unlock Forecast - 30 Days FREE Trial $270M 9.0x 1.0x
FRME Unlock Forecast - 30 Days FREE Trial $2130M 9.4x 0.9x
FRMEP Unlock Forecast - 30 Days FREE Trial $1497M 6.6x 0.6x
FSUN Unlock Forecast - 30 Days FREE Trial $1116M 12.6x 1.0x
FULT Unlock Forecast - 30 Days FREE Trial $3373M 10.4x 1.0x
FULTP Unlock Forecast - 30 Days FREE Trial $3695M 11.4x 1.1x
FUNC Unlock Forecast - 30 Days FREE Trial $226M 9.5x 1.2x
GNTY Unlock Forecast - 30 Days FREE Trial $560M 15.5x 1.7x
HAFC Unlock Forecast - 30 Days FREE Trial $719M 11.0x 0.9x
HBAN Unlock Forecast - 30 Days FREE Trial $24257M 11.5x 1.2x
HBANL Unlock Forecast - 30 Days FREE Trial $37632M 17.8x 1.8x
HBANM Unlock Forecast - 30 Days FREE Trial $34886M 16.5x 1.7x
HBANP Unlock Forecast - 30 Days FREE Trial $27612M 13.1x 1.3x
HOPE Unlock Forecast - 30 Days FREE Trial $1366M 32.8x 0.6x
HWBK Unlock Forecast - 30 Days FREE Trial $206M 10.0x 1.3x
JPM Unlock Forecast - 30 Days FREE Trial $858234M 15.2x 2.4x
JPM-PC Unlock Forecast - 30 Days FREE Trial $71742M 1.3x 0.2x
JPM-PD Unlock Forecast - 30 Days FREE Trial $69916M 1.2x 0.2x
JPM-PJ Unlock Forecast - 30 Days FREE Trial $59916M 1.1x 0.2x
JPM-PK Unlock Forecast - 30 Days FREE Trial $56686M 1.0x 0.2x
JPM-PL Unlock Forecast - 30 Days FREE Trial $57472M 1.0x 0.2x
JPM-PM Unlock Forecast - 30 Days FREE Trial $53511M 1.0x 0.2x
KEY Unlock Forecast - 30 Days FREE Trial $20121M 114.3x 1.0x
KEY-PI Unlock Forecast - 30 Days FREE Trial $27836M 158.2x 1.4x
KEY-PJ Unlock Forecast - 30 Days FREE Trial $25235M 143.4x 1.3x
KEY-PK Unlock Forecast - 30 Days FREE Trial $24847M 141.2x 1.3x
KEY-PL Unlock Forecast - 30 Days FREE Trial $28024M 159.2x 1.4x
LARK Unlock Forecast - 30 Days FREE Trial $150300M 9210.7x 1013.0x
LCNB Unlock Forecast - 30 Days FREE Trial $203M 9.6x 0.8x
MER-PK Unlock Forecast - 30 Days FREE Trial $197754M 7.0x 0.7x
MFG Unlock Forecast - 30 Days FREE Trial $16921M x 0.0x
MRBK Unlock Forecast - 30 Days FREE Trial $163M 8.9x 0.9x
MZHOF Unlock Forecast - 30 Days FREE Trial $88901M x 0.0x
NBHC Unlock Forecast - 30 Days FREE Trial $1420M 11.9x 1.1x
NBTB Unlock Forecast - 30 Days FREE Trial $1953M 14.6x 1.1x
NEWT Unlock Forecast - 30 Days FREE Trial $283M 5.3x 0.9x
NEWTG Unlock Forecast - 30 Days FREE Trial $662M 12.4x 2.1x
NEWTH Unlock Forecast - 30 Days FREE Trial $660M 12.4x 2.1x
NEWTI Unlock Forecast - 30 Days FREE Trial $661M 12.4x 2.1x
NEWTZ Unlock Forecast - 30 Days FREE Trial $662M 12.4x 2.1x
NIC Unlock Forecast - 30 Days FREE Trial $2027M 15.0x 1.7x
NKSH Unlock Forecast - 30 Days FREE Trial $176M 15.6x 1.0x
NWBI Unlock Forecast - 30 Days FREE Trial $1571M 10.9x 1.0x
OCFC Unlock Forecast - 30 Days FREE Trial $1048M 12.0x 0.6x
ONB Unlock Forecast - 30 Days FREE Trial $8522M 15.0x 1.1x
ONBPO Unlock Forecast - 30 Days FREE Trial $9878M 17.4x 1.2x
ONBPP Unlock Forecast - 30 Days FREE Trial $9930M 17.5x 1.2x
OPHC Unlock Forecast - 30 Days FREE Trial $50M 3.4x 0.5x
PFIS Unlock Forecast - 30 Days FREE Trial $459M 13.6x 0.9x
PNFP Unlock Forecast - 30 Days FREE Trial $7071M 11.9x 1.1x
PNFPP Unlock Forecast - 30 Days FREE Trial $1954M 3.3x 0.3x
PRK Unlock Forecast - 30 Days FREE Trial $2564M 15.3x 2.3x
RF Unlock Forecast - 30 Days FREE Trial $22955M 11.1x 1.2x
RF-PC Unlock Forecast - 30 Days FREE Trial $22284M 10.7x 1.2x
RF-PE Unlock Forecast - 30 Days FREE Trial $16887M 8.1x 0.9x
RF-PF Unlock Forecast - 30 Days FREE Trial $23245M 11.2x 1.3x
SFNC Unlock Forecast - 30 Days FREE Trial $2400M 15.0x 0.7x
SFST Unlock Forecast - 30 Days FREE Trial $340M 15.5x 1.0x
SHBI Unlock Forecast - 30 Days FREE Trial $517M 9.6x 0.9x
SMBK Unlock Forecast - 30 Days FREE Trial $569M 13.6x 1.1x
SNNF Unlock Forecast - 30 Days FREE Trial $22M x 0.9x
SNV Unlock Forecast - 30 Days FREE Trial $6704M 8.5x 1.2x
SNV-PD Unlock Forecast - 30 Days FREE Trial $3549M 4.5x 0.6x
SNV-PE Unlock Forecast - 30 Days FREE Trial $3775M 4.8x 0.7x
STEL Unlock Forecast - 30 Days FREE Trial $1589M 14.4x 1.0x
TBBK Unlock Forecast - 30 Days FREE Trial $3669M 16.4x 4.3x
TRMK Unlock Forecast - 30 Days FREE Trial $2391M 11.0x 1.2x
UBFO Unlock Forecast - 30 Days FREE Trial $150M 13.5x 1.1x
UBOH Unlock Forecast - 30 Days FREE Trial $117M 10.3x 1.4x
UMBF Unlock Forecast - 30 Days FREE Trial $9010M 17.1x 1.2x
UMBFO Unlock Forecast - 30 Days FREE Trial $2090M 4.0x 0.3x
USB Unlock Forecast - 30 Days FREE Trial $74024M 10.7x 1.2x
USB-PA Unlock Forecast - 30 Days FREE Trial $1304405M 189.0x 21.2x
USB-PH Unlock Forecast - 30 Days FREE Trial $30144M 4.4x 0.5x
USB-PP Unlock Forecast - 30 Days FREE Trial $37531M 5.4x 0.6x
USB-PQ Unlock Forecast - 30 Days FREE Trial $25209M 3.7x 0.4x
USB-PR Unlock Forecast - 30 Days FREE Trial $26718M 3.9x 0.4x
USB-PS Unlock Forecast - 30 Days FREE Trial $31181M 4.5x 0.5x
VABK Unlock Forecast - 30 Days FREE Trial $204M 11.4x 1.2x
VLY Unlock Forecast - 30 Days FREE Trial $6136M 13.6x 0.8x
VLYPN Unlock Forecast - 30 Days FREE Trial $14683M 32.4x 1.9x
VLYPO Unlock Forecast - 30 Days FREE Trial $14153M 31.3x 1.9x
VLYPP Unlock Forecast - 30 Days FREE Trial $14255M 31.5x 1.9x
VYLD Unlock Forecast - 30 Days FREE Trial $75585M 1.3x 0.2x
WABC Unlock Forecast - 30 Days FREE Trial $1201M 9.5x 1.3x
WAFD Unlock Forecast - 30 Days FREE Trial $2358M 10.4x 0.8x
WAFDP Unlock Forecast - 30 Days FREE Trial $1338M 5.9x 0.4x
WBHC Unlock Forecast - 30 Days FREE Trial $2103M 33.3x 4.0x
WBS Unlock Forecast - 30 Days FREE Trial $9934M 11.6x 1.1x
WBS-PF Unlock Forecast - 30 Days FREE Trial $3384M 4.0x 0.4x
WBS-PG Unlock Forecast - 30 Days FREE Trial $4178M 4.9x 0.5x
WFC Unlock Forecast - 30 Days FREE Trial $265852M 12.9x 1.5x
WFCNP Unlock Forecast - 30 Days FREE Trial $5324M 0.3x 0.0x
WFC-PA Unlock Forecast - 30 Days FREE Trial $65689M 3.2x 0.4x
WFC-PC Unlock Forecast - 30 Days FREE Trial $61030M 3.0x 0.3x
WFC-PD Unlock Forecast - 30 Days FREE Trial $59500M 2.9x 0.3x
WFC-PL Unlock Forecast - 30 Days FREE Trial $4074771M 198.0x 22.5x
WFC-PY Unlock Forecast - 30 Days FREE Trial $82993M 4.0x 0.5x
WFC-PZ Unlock Forecast - 30 Days FREE Trial $66521M 3.2x 0.4x
WSBC Unlock Forecast - 30 Days FREE Trial $3200M 23.7x 0.8x
WSBCP Unlock Forecast - 30 Days FREE Trial $2427M 17.9x 0.6x
WSFS Unlock Forecast - 30 Days FREE Trial $3072M 11.5x 1.2x
ZION Unlock Forecast - 30 Days FREE Trial $8241M 9.8x 1.3x
ZIONP Unlock Forecast - 30 Days FREE Trial $3231M 3.8x 0.5x

Frequently Asked Questions - AMES NATIONAL CORP Stock Forecast

How accurate are AMES NATIONAL CORP stock predictions?

Our AI model demonstrates 58% historical accuracy for ATLO predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence AMES NATIONAL CORP stock price forecasts?

Our analysis considers AMES NATIONAL CORP's financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is AMES NATIONAL CORP a good investment in 2025?

Based on our AI analysis, AMES NATIONAL CORP shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are AMES NATIONAL CORP forecasts updated?

AMES NATIONAL CORP stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced AMES NATIONAL CORP Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for AMES NATIONAL CORP stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...